neoadjuvant therapy
MRCTA.ECFAH of FMU[2023]405
Approved other active
Quick answer
neoadjuvant therapy for Hepatocellular Carcinoma Resectable is a Approved program (other) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Hepatocellular Carcinoma Resectable
- Phase
- Approved
- Modality
- other
- Status
- active